These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
337 related items for PubMed ID: 15809058
1. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress. Nourooz-Zadeh J, Cooper MB, Ziegler D, Betteridge DJ. Biochem Biophys Res Commun; 2005 May 13; 330(3):731-6. PubMed ID: 15809058 [Abstract] [Full Text] [Related]
2. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Mori TA, Croft KD, Puddey IB, Beilin LJ. Anal Biochem; 1999 Mar 01; 268(1):117-25. PubMed ID: 10036170 [Abstract] [Full Text] [Related]
3. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Morrow JD, Zackert WE, Yang JP, Kurhts EH, Callewaert D, Dworski R, Kanai K, Taber D, Moore K, Oates JA, Roberts LJ. Anal Biochem; 1999 May 01; 269(2):326-31. PubMed ID: 10222005 [Abstract] [Full Text] [Related]
4. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. Schweer H, Watzer B, Seyberth HW, Nüsing RM. J Mass Spectrom; 1997 Dec 01; 32(12):1362-70. PubMed ID: 9423285 [Abstract] [Full Text] [Related]
5. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine. Schwedhelm E, Tsikas D, Durand T, Gutzki FM, Guy A, Rossi JC, Frölich JC. J Chromatogr B Biomed Sci Appl; 2000 Jul 07; 744(1):99-112. PubMed ID: 10985571 [Abstract] [Full Text] [Related]
6. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry. Davies SS, Zackert W, Luo Y, Cunningham CC, Frisard M, Roberts LJ. Anal Biochem; 2006 Jan 15; 348(2):185-91. PubMed ID: 16309621 [Abstract] [Full Text] [Related]
7. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man. Bachi A, Brambilla R, Fanelli R, Bianchi R, Zuccato E, Chiabrando C. Br J Pharmacol; 1997 Aug 15; 121(8):1770-4. PubMed ID: 9283716 [Abstract] [Full Text] [Related]
8. Impact of diabetic polyneuropathy and cardiovascular autonomic neuropathy on the excretion of urinary 8-epi-PGF2alpha and its metabolites (2, 3-dinor and 2, 3-dinor-5, 6-dihydro). Nourooz-Zadeh J, Sohr CG, Durand T, Ziegler D. Free Radic Res; 2006 Jul 15; 40(7):723-9. PubMed ID: 16983999 [Abstract] [Full Text] [Related]
9. Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-Prostaglandin F2alpha. Chiabrando C, Valagussa A, Rivalta C, Durand T, Guy A, Zuccato E, Villa P, Rossi JC, Fanelli R. J Biol Chem; 1999 Jan 15; 274(3):1313-9. PubMed ID: 9880501 [Abstract] [Full Text] [Related]
10. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J, Gutzki FM, Berger J, Frölich JC, Böger RH. Circulation; 2004 Feb 24; 109(7):843-8. PubMed ID: 14757688 [Abstract] [Full Text] [Related]
11. Key issues in F2-isoprostane analysis. Nourooz-Zadeh J. Biochem Soc Trans; 2008 Oct 24; 36(Pt 5):1060-5. PubMed ID: 18793189 [Abstract] [Full Text] [Related]
12. F(2)-isoprostane and prostaglandin F(2 alpha)metabolite excretion rate and day to day variation in healthy humans. Helmersson J, Basu S. Prostaglandins Leukot Essent Fatty Acids; 2001 Aug 24; 65(2):99-102. PubMed ID: 11545626 [Abstract] [Full Text] [Related]
13. Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane. Il'yasova D, Morrow JD, Ivanova A, Wagenknecht LE. Ann Epidemiol; 2004 Nov 24; 14(10):793-7. PubMed ID: 15519902 [Abstract] [Full Text] [Related]
14. Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans. Roberts LJ, Moore KP, Zackert WE, Oates JA, Morrow JD. J Biol Chem; 1996 Aug 23; 271(34):20617-20. PubMed ID: 8702808 [Abstract] [Full Text] [Related]
15. Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2α, in biological samples by GC-MS or GC-MS/MS coupled with immunoaffinity column chromatography. Tsikas D, Suchy MT. J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr 15; 1019():191-201. PubMed ID: 25583542 [Abstract] [Full Text] [Related]
16. Determination of 8-epi PGF(2alpha) concentrations as a biomarker of oxidative stress using triple-stage liquid chromatography/tandem mass spectrometry. Bastani NE, Gundersen TE, Blomhoff R. Rapid Commun Mass Spectrom; 2009 Sep 15; 23(18):2885-90. PubMed ID: 19670343 [Abstract] [Full Text] [Related]
17. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA, FitzGerald GA. Circulation; 1997 Nov 18; 96(10):3314-20. PubMed ID: 9396422 [Abstract] [Full Text] [Related]
18. Measurement of urinary 8-Epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers. Bachi A, Zuccato E, Baraldi M, Fanelli R, Chiabrando C. Free Radic Biol Med; 1996 Nov 18; 20(4):619-24. PubMed ID: 8904305 [Abstract] [Full Text] [Related]
19. Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitor. Smedman A, Vessby B, Basu S. Clin Sci (Lond); 2004 Jan 18; 106(1):67-73. PubMed ID: 12956622 [Abstract] [Full Text] [Related]